Valneva SE
Specialty vaccine company developing and commercializing vaccines for infectious diseases.
VLA | PA
Overview
Corporate Details
- ISIN(s):
- AT0000A10B99 (+3 more)
- LEI:
- 969500DIVIP5VKNW4948
- Country:
- France
- Address:
- 6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN
- Website:
- https://valneva.com/
- Sector:
- Manufacturing
Description
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2010-10-20 23:42 |
VIVALIS ACCELERE SA DYNAMIQUE DE CROISSANCE AVEC UNE HAUSSE DE 45% DU CHIFFRE D…
|
French | 91.8 KB | ||
| 2010-10-12 17:40 |
VIVALIS ET KITASATO SIGNENT UNE LICENCE DE RECHERCHE POUR EVALUER LA LIGNEE CE…
|
French | 75.4 KB | ||
| 2010-10-07 17:45 |
VIVALIS : DECLARATION D'ACTIONS ET DROIT DE VOTE
|
French | 52.0 KB | ||
| 2010-10-05 17:40 |
VIVALIS signe un nouvel accord d'évaluation de la lignée cellulaire EB66® pour …
|
French | 75.6 KB | ||
| 2010-09-28 17:40 |
VIVALIS SIGNE UNE NOUVELLE LICENCE DE RECHERCHE EB66 AVEC MYMETICS CORPORATION
|
French | 75.3 KB | ||
| 2010-09-03 17:40 |
VIVALIS : DECLARATION D'ACTIONS ET DROIT DE VOTE
|
French | 7.3 KB | ||
| 2010-08-31 17:40 |
VIVALIS PUBLISHES ITS RESULTS FOR THE FIRST HALF AND CONFIRMS 2010 TARGETS
|
English | 107.8 KB | ||
| 2010-08-31 17:40 |
VIVALIS PUBLIE SES COMPTES POUR LE PREMIER SEMESTRE ET CONFIRME SES OBJECTIFS 2…
|
French | 108.9 KB | ||
| 2010-08-31 17:35 |
VIVALIS : RAPPORT FINANCIER SEMESTRIEL : 1 JANVIER AU 30 JUIN 2010
|
French | 997.9 KB | ||
| 2010-08-03 17:45 |
VIVALIS ACTIONS ET DROITS DE VOTE JUILLET 2010
|
French | 7.3 KB | ||
| 2010-07-26 17:40 |
VIVALIS RAISES OVER EUR 30 MILLION IN SUCCESSFUL RIGHTS ISSUE OVERSUBSCRIBED BY…
|
English | 91.0 KB | ||
| 2010-07-26 17:40 |
VIVALIS : LEVEE DE PLUS DE 30 MILLIONS D'EUROS, AUGMENTATION DE CAPITAL SURSOUS…
|
French | 97.4 KB | ||
| 2010-07-21 17:40 |
VIVALIS ACCELERATES GROWTH: FIRST HALF REVENUES UP 28%
|
English | 107.4 KB | ||
| 2010-07-21 17:40 |
VIVALIS ACCELERE SA CROISSANCE : CHIFFRE D'AFFAIRES DU PREMIER SEMESTRE EN HAUS…
|
French | 102.7 KB | ||
| 2010-07-19 17:40 |
VIVALIS SIGNS EB66® COMMERCIAL LICENSE WITH BOEHRINGER INGELHEIM VETMEDICA
|
English | 94.8 KB |
Automate Your Workflow. Get a real-time feed of all Valneva SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Valneva SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Valneva SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-03-18 | N/A | Other | Buy | 44,222 | N/A |
| 2024-01-03 | N/A | Other | Other | 34,802 | N/A |
| 2023-06-20 | N/A | Other | Sell | 192,547 | 1,406,228.50 EUR |
| 2023-06-19 | N/A | Other | Sell | 30,661 | 209,629.26 EUR |
| 2023-06-16 | N/A | Other | Sell | 85,589 | 582,493.06 EUR |
| 2023-06-15 | N/A | Other | Sell | 28,179 | 189,503.78 EUR |
| 2023-06-14 | N/A | Other | Sell | 228,951 | 1,519,914.11 EUR |
| 2023-06-13 | N/A | Other | Sell | 29,401 | 187,922.37 EUR |
| 2023-06-12 | N/A | Other | Sell | 117,854 | 733,782.57 EUR |
| 2023-05-10 | N/A | Other | Buy | 87,523 | N/A |
Peer Companies
